subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix

object_name: metastatic prostate carcinoma


subject: UMLS:C0971731

tested_intervention: unsure


subject: CHEBI:6427

subject_name: Leuprolide

tested_intervention: yes


subject: UMLS:C4053601


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Fractured rib


subject: CHEBI:50673

subject_name: Methimazole

object_name: Graves disease


subject: CHEBI:50673

object_name: atherosclerosis


subject: CHEBI:50673

object_name: Functional disorder


subject: CHEBI:8502

subject_name: Propylthiouracil

object_name: hyperthyroidism


subject: CHEBI:8502

object_name: Hyperthyroidism, CTCAE


subject: CHEBI:8502


subject: CHEBI:8502


subject: CHEBI:8502


subject: CHEBI:9123

subject_name: Sertraline

object_name: Myelodysplasia


subject: UMLS:C1722701

subject_name: Licartin

object_name: liver carcinoma


subject: UMLS:C3897088

subject_name: Oral Azacitidine

object_name: diffuse large B-cell lymphoma


subject: UMLS:C3897088

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C3897088

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:31355

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:31355

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:31355

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:31355

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:31355

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:31355

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: HER2/Neu Negative


subject: CHEBI:31355

object_name: Estrogen Receptor Negative


subject: CHEBI:31355

object_name: Progesterone Receptor Negative


subject: CHEBI:31355

object_name: breast adenocarcinoma


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Stomach cancer


subject: CHEBI:94518

object_name: gastric cancer


subject: CHEBI:94518

object_name: adult hepatocellular carcinoma


subject: CHEBI:94518

object_name: liver cancer


subject: CHEBI:94518

object_name: pediatric hepatocellular carcinoma


subject: CHEBI:94518

object_name: liver carcinoma


subject: CHEBI:94518

object_name: pancreatic neoplasm


subject: CHEBI:94518

object_name: exocrine pancreatic carcinoma


subject: CHEBI:94518

object_name: malignant pancreatic neoplasm


subject: CHEBI:94518

object_name: colon carcinoma


subject: CHEBI:94518

object_name: colorectal cancer


subject: CHEBI:94518

object_name: colon cancer


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: intrahepatic cholangiocarcinoma


subject: UMLS:C3641122


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: acute liver failure


subject: CHEBI:6888

object_name: Fulminant hepatic failure


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: UMLS:C0085826

subject_name: Antiplatelet Agents

object_name: cardiac arrest


subject: UMLS:C0085826

object_name: Cardiac Arrest, CTCAE


subject: UMLS:C0085826

object_name: Platelet dysfunction


subject: PUBCHEM.COMPOUND:156501355


subject: PUBCHEM.COMPOUND:156501355

object_name: Metastatic Adult Malignant Neoplasm in the Brain


subject: PUBCHEM.COMPOUND:156501355

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: non-small cell lung carcinoma


subject: CHEBI:63587

subject_name: Eribulin


subject: UMLS:C1506837


subject: UMLS:C2350844

object_name: sickle cell disease


subject: CHEBI:47499

subject_name: Imipramine

object_name: panic disorder


subject: CHEBI:47499

object_name: panic disorder 1


subject: PUBCHEM.COMPOUND:9914270

subject_name: Landiolol

object_name: Tachycardia by ECG Finding


subject: PUBCHEM.COMPOUND:9914270

object_name: Tachycardia


subject: PUBCHEM.COMPOUND:9914270

object_name: septic shock


subject: CHEBI:82339

subject_name: Merphalan

object_name: Childhood Breast Carcinoma


subject: CHEBI:82339

object_name: breast carcinoma


subject: CHEBI:82339

object_name: breast cancer


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: UMLS:C1134558

subject_name: Chinese Herbs

object_name: infertility


subject: UMLS:C1134558

object_name: placental abruption


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: dyspepsia


subject: CHEBI:9943

object_name: Dyspepsia, CTCAE


subject: PUBCHEM.COMPOUND:6918224

subject_name: QUETIAPINE FUMARATE

object_name: generalized anxiety disorder


subject: GTOPDB:13629

subject_name: bevasiranib

object_name: diabetic macular edema


subject: UNII:DGN36694W4

subject_name: Bevasiranib


subject: CHEBI:30884

subject_name: glycoloyl group

object_name: non-small cell lung carcinoma


subject: CHEBI:73890

subject_name: Gly-Cys


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin

object_name: viral disease


subject: UNII:8NZ41MIK1O

object_name: thrombophilia due to thrombin defect


subject: UMLS:C3896906

object_name: neoplasm


subject: UNII:621XR2W6OP

subject_name: Methylprednisone

object_name: Acute exacerbation of idiopathic pulmonary fibrosis


subject: PUBCHEM.COMPOUND:5126752


subject: CHEBI:135573

subject_name: Meprednisone


subject: CHEBI:8382

subject_name: Prednisone


subject: UMLS:C5203470

subject_name: Obinutuzumab Liquid Injection

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: gastroparesis


subject: CHEBI:3160

object_name: Gastroparesis, CTCAE


subject: CHEBI:521033

subject_name: Dutasteride

object_name: Depressed mood


subject: CHEBI:521033

object_name: Cancer patients and suicide and depression


subject: CHEBI:521033

object_name: Depressed - symptom


subject: CHEBI:521033

object_name: Depression, CTCAE


subject: CHEBI:521033

object_name: premenstrual tension


subject: CHEBI:521033

object_name: polydactyly-myopia syndrome


subject: CHEBI:31515

subject_name: Domperidone


subject: CHEBI:31515


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: reported history of cataract surgery


subject: PUBCHEM.COMPOUND:9824461

object_name: Cognitive impairment


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Back Pain, CTCAE 5.0


subject: UMLS:C0445115

object_name: Back pain


subject: UMLS:C0445115

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:17688

subject_name: Nicotine

object_name: Nicotine Use Disorder


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: graft versus host disease


subject: CHEBI:91397

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:91397

object_name: non-Hodgkin lymphoma


subject: CHEBI:91397

object_name: B-cell neoplasm


subject: CHEBI:91397

object_name: B-Cell Leukemia


subject: CHEBI:91397

object_name: Childhood Solid Neoplasm


subject: CHEBI:91397

object_name: Adult Solid Neoplasm


subject: CHEBI:91397

object_name: Solid Neoplasm


subject: CHEBI:94789

subject_name: Trimetazidine

object_name: Pre-capillary pulmonary hypertension


subject: UNII:YI437801BE

subject_name: Mogamulizumab

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UNII:YI437801BE

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:7773

subject_name: Ondansetron

object_name: substance-related disorder


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: postpartum hemorrhage


subject: CHEBI:4466

object_name: Post-partum hemorrhage


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:17688

object_name: mental disorder


subject: CHEBI:17688

object_name: psychiatric disorder


subject: CHEBI:17688

object_name: History of - psychiatric disorder


subject: CHEBI:17688

object_name: endogenous depression


subject: CHEBI:17688

object_name: major depressive disorder


subject: CHEBI:17688

object_name: bipolar II disorder


subject: CHEBI:17688

object_name: psychosis


subject: CHEBI:17688

object_name: bipolar I disorder


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch


subject: UMLS:C0358855


subject: UMLS:C0358855


subject: UMLS:C0358855


subject: UMLS:C0358855


subject: UMLS:C0358855


subject: UMLS:C0358855


subject: UMLS:C0358855


subject: UMLS:C0358855

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: Chronic liver disease


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:9907

subject_name: ursodiol


subject: CHEBI:9907

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:72191360

object_name: Ischemic stroke


subject: PUBCHEM.COMPOUND:72191360

object_name: arteriosclerosis disorder


subject: PUBCHEM.COMPOUND:72191360

object_name: atherosclerosis


subject: UNII:MT7GG73BQT


subject: UNII:MT7GG73BQT


subject: UNII:MT7GG73BQT


subject: CHEBI:6121

subject_name: Ketamine

object_name: cognitive disorder


subject: CHEBI:6121

object_name: Inflammation


subject: CHEBI:6121

object_name: Presenile dementia


subject: CHEBI:6121

object_name: dementia


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: diabetes mellitus


subject: CHEBI:51450

subject_name: Bosentan


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: Depressed mood


subject: UNII:71M78END5S

object_name: Cancer patients and suicide and depression


subject: UNII:71M78END5S

object_name: Depressed - symptom


subject: UNII:71M78END5S

object_name: Depression, CTCAE


subject: UNII:71M78END5S

object_name: Maternity blues


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:37144

subject_name: epichlorohydrin


subject: CHEBI:37144


subject: CHEBI:37144


subject: CHEBI:37144


subject: CHEBI:37144


subject: CHEBI:28364

subject_name: Icosapent


subject: CHEBI:28364


subject: CHEBI:28364


subject: CHEBI:28364


subject: CHEBI:28364


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: PR:000016352


subject: PR:000016352


subject: PR:000016352


subject: PR:000016352


subject: CHEBI:36005

subject_name: docosahexaenoic acid


subject: CHEBI:36005


subject: CHEBI:36005


subject: CHEBI:36005


subject: CHEBI:36005


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: influenza


subject: CHEBI:38545

object_name: swine influenza


subject: CHEBI:38545

object_name: acute respiratory distress syndrome


subject: CHEBI:38545

object_name: adult acute respiratory distress syndrome


subject: UMLS:C1176021

object_name: neoplasm


subject: UMLS:C3886595

object_name: tuberculosis


subject: UMLS:C3541932

subject_name: Moringa oleifera extract

object_name: postmenopausal osteoporosis


subject: UMLS:C3541932

object_name: Osteopenia/osteoporosis


subject: UMLS:C3541932

object_name: Osteopenia


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:21634109

object_name: alcohol dependence


subject: UMLS:C0699857

subject_name: Nitrate

object_name: hypertension


subject: UMLS:C0699857

object_name: Hypertension, CTCAE


subject: UMLS:C0699857

object_name: cardiovascular disorder


subject: CHEBI:17632


subject: CHEBI:17632


subject: CHEBI:17632


subject: CHEBI:48107

subject_name: Nitric acid


subject: CHEBI:48107


subject: CHEBI:48107


subject: CHEMBL.COMPOUND:CHEMBL3545103

object_name: asthma


subject: CHEMBL.COMPOUND:CHEMBL3545103

object_name: obstructive lung disease


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: adult germ cell tumor


subject: CHEBI:45863

object_name: germ cell tumor


subject: CHEBI:45863

object_name: childhood germ cell tumor


subject: CHEBI:45863

object_name: Germ Cell Cancer


subject: CHEBI:64312

subject_name: Memantine

object_name: Cirrhosis


subject: CHEBI:64312

object_name: liver cirrhosis


subject: CHEBI:64312

object_name: liver carcinoma


subject: UNII:4988K7X26P

subject_name: Fosamax

object_name: Intrabony periodontal defect


subject: CHEBI:2567

subject_name: Alendronic acid


subject: PR:000022672

subject_name: flagellar regulator flk

object_name: Depressed mood


subject: PR:000022672

object_name: Cancer patients and suicide and depression


subject: PR:000022672

object_name: Depressed - symptom


subject: PR:000022672

object_name: Depression, CTCAE


subject: PR:000022672

object_name: bipolar disorder


subject: CHEBI:157844

subject_name: Glu-Arg


subject: CHEBI:157844


subject: CHEBI:157844


subject: CHEBI:157844


subject: CHEBI:157844


subject: CHEBI:33379

subject_name: erbium


subject: CHEBI:33379


subject: CHEBI:33379


subject: CHEBI:33379


subject: CHEBI:33379


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: UMLS:C5441529


subject: UMLS:C5441529


subject: UMLS:C5441529


subject: UMLS:C5441529


subject: PR:000007204

subject_name: estrogen receptor


subject: PR:000007204


subject: PR:000007204


subject: PR:000007204


subject: PR:000007204


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Renal transplant failure


subject: CHEBI:85078

object_name: kidney failure


subject: CHEBI:85078

object_name: Adverse Event Associated with Death


subject: CHEBI:85078

object_name: Death (finding)


subject: CHEBI:85078

object_name: Death


subject: CHEBI:73611

subject_name: Met-Gly

object_name: peripheral nerve injury


subject: CHEBI:25107

subject_name: magnesium atom


subject: PR:000004501

subject_name: attractin


subject: UMLS:C0487173

subject_name: Mg antigen


subject: MESH:C586184

object_name: acute myeloid leukemia


subject: UMLS:C2981800


subject: CHEBI:60775

subject_name: Verteporfin

object_name: Carcinoma breast stage IV


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: UNII:UVJ7NL8S2P

subject_name: Imlifidase

object_name: chronic hepatitis B virus infection


subject: UNII:UVJ7NL8S2P

object_name: hepatitis B


subject: PUBCHEM.COMPOUND:4442

subject_name: Ramosetron

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:4442

object_name: prostate cancer


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: neurofibromatosis 1


subject: CHEBI:28939

object_name: neurofibromatosis type 1


subject: CHEBI:64073

object_name: glucose intolerance


subject: CHEBI:64073

object_name: Impaired glucose tolerance


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: CHEBI:94686

subject_name: Orlistat

object_name: Androgen excess


subject: CHEBI:94686

object_name: Prediabetes


subject: CHEBI:94686


subject: CHEBI:94686


subject: CHEBI:2376

subject_name: acarbose


subject: CHEBI:2376


subject: CHEBI:2376


subject: CHEBI:2376


subject: GTOPDB:2943

subject_name: secretin

object_name: obesity


subject: GTOPDB:2943

object_name: metabolic disease


subject: GTOPDB:2943

object_name: type 2 diabetes mellitus


subject: GTOPDB:2943

object_name: Diabetes


subject: GTOPDB:2943

object_name: diabetes mellitus


subject: GTOPDB:2943

object_name: obesity due to melanocortin 4 receptor deficiency


subject: GTOPDB:2943

object_name: Obesity, CTCAE


subject: CHEBI:232390


subject: CHEBI:232390


subject: CHEBI:232390


subject: CHEBI:232390


subject: CHEBI:232390


subject: CHEBI:232390


subject: CHEBI:232390


subject: CHEBI:31348

subject_name: Capecitabine

object_name: renal cell adenocarcinoma


subject: CHEBI:31348

object_name: kidney cancer


subject: CHEBI:31348

object_name: renal cell carcinoma


subject: CHEBI:31348

object_name: childhood kidney cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON


subject: CHEMBL.COMPOUND:CHEMBL2108494


subject: CHEMBL.COMPOUND:CHEMBL2108494


subject: CHEMBL.COMPOUND:CHEMBL2108494


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C3652465


subject: UMLS:C3652465


subject: UMLS:C3652465


subject: UMLS:C0021747

subject_name: Interferons


subject: UMLS:C0021747


subject: UMLS:C0021747


subject: UMLS:C0021747


subject: UMLS:C0733470

subject_name: human leukocyte interferon


subject: UMLS:C0733470


subject: UMLS:C0733470


subject: UMLS:C0733470


subject: UMLS:C0021764

subject_name: Interleukins


subject: UMLS:C0021764


subject: UMLS:C0021764


subject: UMLS:C0021764


subject: UMLS:C5540068

subject_name: olanzapine / samidorphan

object_name: schizoaffective disorder


subject: UMLS:C5540068

object_name: schizophrenia 18


subject: UMLS:C5540068

object_name: schizophrenia


subject: UMLS:C5540068

object_name: bipolar disorder


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Carcinoma breast stage IV


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UMLS:C5222461

subject_name: Lidocaine Hydrochloride Liquid Injection

object_name: obstructive sleep apnea syndrome


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:233453

object_name: sexually transmitted disease


subject: CHEBI:233453

object_name: herpes simplex


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:173106

subject_name: ferroptocide

object_name: AIDS


subject: CHEBI:63625

subject_name: Tenofovir


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: PUBCHEM.COMPOUND:23083982

subject_name: Elvitegravir


subject: CHEBI:3125

subject_name: Bisacodyl

object_name: colon carcinoma


subject: CHEBI:3125

object_name: colorectal cancer


subject: CHEBI:3125

object_name: colon cancer


subject: CHEBI:3125

object_name: polyp of colon


subject: CHEBI:3125

object_name: Encounter due to family history of colonic polyps


subject: CHEBI:3125

object_name: inflammatory bowel disease


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: metastatic prostate carcinoma


subject: CHEBI:17596

subject_name: Inosine

object_name: lung disorder


subject: CHEBI:17596

object_name: bronchopulmonary dysplasia


subject: CHEBI:17596

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: CHEBI:16411


subject: CHEBI:16411


subject: PUBCHEM.COMPOUND:24892726

subject_name: Glucomannan

object_name: metabolic dysfunction-associated steatotic liver disease


subject: PUBCHEM.COMPOUND:24892726

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:24892726

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:24892726

object_name: abdominal obesity-metabolic syndrome


subject: PUBCHEM.COMPOUND:24892726

object_name: metabolic syndrome X


subject: CHEBI:74705

subject_name: Met-Leu

object_name: metastatic colorectal cancer


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: DRUGBANK:DB17545

subject_name: Jaktinib

object_name: myelofibrosis


subject: MESH:C576493

subject_name: Meopa

object_name: Renal Colic, CTCAE


subject: MESH:C576493

object_name: renal colic


subject: DRUGBANK:DB14366

subject_name: Ilex paraguariensis leaf

object_name: obesity due to melanocortin 4 receptor deficiency


subject: DRUGBANK:DB14366

object_name: obesity


subject: DRUGBANK:DB14366

object_name: Obesity, CTCAE


subject: CHEBI:33387

subject_name: neptunium atom

object_name: HIV infection


subject: CHEBI:53793

subject_name: (4-hydroxy-3-nitrophenyl)acetyl group


subject: CHEBI:73425

subject_name: Asn-Pro


subject: CHEBI:50803

subject_name: nanoparticle


subject: MESH:C058314

subject_name: nucleoprotein, Measles virus


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: psoriasis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:31355

subject_name: Carboplatin

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:31355

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:31355

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:31355

object_name: Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:31355

object_name: Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEBI:31355

object_name: Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:31355

object_name: Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEBI:31355

object_name: Nodal marginal zone B-cell lymphoma refractory


subject: CHEBI:31355

object_name: Nodal marginal zone B-cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab


subject: UNII:D6OMY2L0WA

object_name: Diffuse large B-cell lymphoma recurrent


subject: UNII:D6OMY2L0WA


subject: UNII:D6OMY2L0WA


subject: UNII:D6OMY2L0WA


subject: UNII:D6OMY2L0WA


subject: UNII:D6OMY2L0WA


subject: UNII:D6OMY2L0WA


subject: UNII:D6OMY2L0WA


subject: UNII:D6OMY2L0WA


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Labor Pain


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:7454

subject_name: Nalbuphine


subject: GTOPDB:13876

subject_name: nipocalimab

object_name: fetal and neonatal alloimmune thrombocytopenia


subject: GTOPDB:13876

object_name: neonatal thrombocytopenia


subject: UNII:87M90CV8NC

subject_name: NIPOCALIMAB


subject: UNII:87M90CV8NC


subject: UMLS:C5417823


subject: UMLS:C5417823


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: cancer


subject: UNII:82JB1524Q6

subject_name: Ombrabulin


subject: UMLS:C0910081


subject: CHEBI:9434

subject_name: Telmisartan

object_name: graft versus host disease


subject: GTOPDB:12969

subject_name: tarlatamab

object_name: Small cell lung cancer extensive stage


subject: UNII:74X82ST8Q1

subject_name: TARLATAMAB


subject: UMLS:C4687660

subject_name: AMG 757


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB

object_name: Locally Advanced Esophageal Squamous Cell Carcinoma


subject: UMLS:C4331912


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: Laryngopharyngeal Reflux


subject: CHEBI:77260

subject_name: Omeprazole


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Neck Carcinoma


subject: UNII:5S371K6132

object_name: head and neck neoplasm


subject: UNII:5S371K6132

object_name: head and neck cancer


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: EXCESS LMW-DNA


subject: CHEBI:38545

object_name: atherosclerosis


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: prostate adenocarcinoma


subject: CHEBI:169833

subject_name: Deacetyldiltiazem

object_name: coronary artery intramyocardial course


subject: CHEBI:82814

subject_name: Dilacor XR


subject: CHEBI:101278

subject_name: Diltiazem


subject: CHEBI:64019

subject_name: Nebivolol


subject: UMLS:C3658170

object_name: prostatitis


subject: UMLS:C3658170

object_name: Prostatitis category III (National Institute of Health classification)


subject: UNII:N5UK68MGDZ

subject_name: Apremilast


subject: UNII:N5UK68MGDZ


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: multiple system atrophy


subject: CHEBI:50847

object_name: neurodegenerative disease


subject: CHEBI:229225

subject_name: Bexagliflozin

object_name: sleep apnea


subject: CHEBI:229225

object_name: Sleep Apnea, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2108621

subject_name: MAPATUMUMAB

object_name: plasma cell myeloma


subject: UMLS:C1541394

subject_name: TRAIL-R1 mAb


subject: CHEBI:28262

subject_name: Dimethyl sulfoxide

object_name: Urinary Urgency


subject: CHEBI:28262

object_name: Detrusor instability


subject: CHEBI:28262

object_name: Neurogenic detrusor overactivity


subject: UNII:3977IRA64J

subject_name: Isopentyl 2-cyanoacrylate

object_name: hydrosalpinx


subject: UNII:3977IRA64J

object_name: female infertility


subject: PUBCHEM.COMPOUND:9874151

subject_name: Angeliq

object_name: hypertension


subject: PUBCHEM.COMPOUND:9874151

object_name: Hypertension, CTCAE


subject: UMLS:C1455162


subject: UMLS:C1455162


subject: CHEBI:50838

subject_name: Drospirenone


subject: CHEBI:50838


subject: UMLS:C0732850

subject_name: Propess

object_name: Birthing Labor


subject: UMLS:C0732850

object_name: Premature rupture of membranes


subject: CHEBI:15551

subject_name: Dinoprostone


subject: CHEBI:15551


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: infectious otitis media


subject: CHEBI:51254

object_name: Acute otitis media


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: UMLS:C1171096

subject_name: Augmentin ES-600


subject: UMLS:C1171096


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Androgen excess


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Postoperative delirium


subject: CHEBI:4466

object_name: Inflammation


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:25805

subject_name: oxygen atom

object_name: heart failure


subject: CHEBI:25805

object_name: Heart Failure, CTCAE


subject: CHEBI:25805

object_name: central sleep apnea syndrome


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: CHEBI:15379


subject: CHEBI:15765

subject_name: Levodopa

object_name: schizophrenia


subject: CHEBI:3395

subject_name: carbidopa


subject: CHEBI:94430

subject_name: DL-Carbidopa


subject: CHEBI:39585

subject_name: Carbidopa


subject: UMLS:C2703099

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C2703099

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C2703099

object_name: metastatic melanoma


subject: UMLS:C2703099

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Miller-Dieker lissencephaly syndrome


subject: PUBCHEM.COMPOUND:1805

object_name: myoclonic dystonia 11


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: UNII:09OB3E5QTD

object_name: chronic myelomonocytic leukemia


subject: UNII:09OB3E5QTD

object_name: Myelodysplasia


subject: UNII:09OB3E5QTD


subject: UNII:09OB3E5QTD


subject: UNII:09OB3E5QTD

object_name: acute myeloid leukemia


subject: UNII:09OB3E5QTD

object_name: juvenile myelomonocytic leukemia


subject: UNII:09OB3E5QTD

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3886555


subject: UMLS:C3886555


subject: UMLS:C3886555


subject: UMLS:C3886555


subject: UMLS:C3886555


subject: UMLS:C3886555


subject: UMLS:C3886555


subject: UNII:9TD681796G

subject_name: Sitafloxacin

object_name: pulmonary tuberculosis


subject: CHEBI:4304

subject_name: sitafloxacin


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: coronary artery disorder


subject: CHEBI:73604

object_name: coronary atherosclerosis


subject: CHEBI:231681

subject_name: olaratumab

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:231681

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:231681

object_name: sarcoma


subject: CHEBI:231681

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:231681

object_name: soft tissue sarcoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Steroid-dependent nephrotic syndrome


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:30868AY0IF

object_name: polyp of colon


subject: CHEBI:135193

subject_name: Fospropofol


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole

object_name: acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:147912


subject: PUBCHEM.COMPOUND:147912


subject: CHEBI:63918

subject_name: Artesunate

object_name: liver carcinoma


subject: CHEBI:46692

object_name: leukemia


subject: CHEBI:46692

object_name: childhood leukemia


subject: UMLS:C0541491

subject_name: Drugs and Biologicals

object_name: rheumatoid arthritis


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Evidence of liver transplantation


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:9150

subject_name: Simvastatin

object_name: esophageal varices


subject: CHEBI:9150

object_name: liver cirrhosis


subject: CHEBI:499361

subject_name: Aprepitant

object_name: Vomiting, CTCAE


subject: CHEBI:499361

object_name: Nausea, CTCAE_5


subject: CHEBI:499361

object_name: Nausea


subject: CHEBI:499361

object_name: Nausea, CTCAE_3


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Synovitis of knee


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: PUBCHEM.COMPOUND:9847786

subject_name: TOLTERODINE TARTRATE

object_name: Urinary Urgency


subject: CHEBI:6078

subject_name: Ivermectin

object_name: Pediculosis


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:73272

object_name: obesity


subject: CHEBI:73272

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin


subject: PUBCHEM.COMPOUND:74323022


subject: PUBCHEM.COMPOUND:74323022


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: ischemia


subject: CHEBI:68558

subject_name: Ticagrelor


subject: UNII:GGL7785YRX

object_name: Childhood Breast Carcinoma


subject: UNII:GGL7785YRX

object_name: breast carcinoma


subject: UNII:GGL7785YRX

object_name: breast cancer


subject: UMLS:C5777119


subject: UMLS:C5777119


subject: UMLS:C5777119


subject: PUBCHEM.COMPOUND:578771

subject_name: Betamethasone 17 Valerate

object_name: paronychia


subject: PUBCHEM.COMPOUND:578771

object_name: Paronychia, CTCAE


subject: CHEBI:3077

subject_name: Betamethasone


subject: CHEBI:3077


subject: UMLS:C0593250

subject_name: Topical timolol


subject: UMLS:C0593250


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: primary ovarian failure


subject: UMLS:C0013227

object_name: premature menopause


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: GTOPDB:4386

subject_name: FSH


subject: GTOPDB:4386


subject: UMLS:C0016424

subject_name: Follicle stimulating hormone injectable


subject: UMLS:C0016424


subject: CHEBI:81569

subject_name: Follitropin


subject: CHEBI:81569


subject: UMLS:C0016774

subject_name: Human Follicle-Stimulating Hormone


subject: UMLS:C0016774


subject: UNII:210323T9CP

object_name: chronic pain (diagnosis)


subject: UNII:210323T9CP

object_name: Chronic pain


subject: PUBCHEM.COMPOUND:24752296


subject: PUBCHEM.COMPOUND:24752296


subject: CHEBI:132922

object_name: common cold


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:4696

subject_name: donepezil hydrochloride

object_name: Well adult


subject: CHEBI:145499

subject_name: Donepezil


subject: UMLS:C2700098

subject_name: Vargatef

object_name: ovarian cancer


subject: UMLS:C2700098

object_name: ovarian neoplasm


subject: UMLS:C2700098

object_name: ovarian carcinoma


subject: CHEBI:84500

subject_name: varenicline

object_name: methamphetamine dependence


subject: CHEBI:84500

object_name: Harmful pattern of use of methamphetamine


subject: CHEBI:84500

object_name: Harmful pattern of substance use


subject: CHEBI:84500

object_name: substance abuse


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: colorectal cancer


subject: UMLS:C3827032

object_name: colorectal carcinoma


subject: UMLS:C3827032

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3827032

object_name: rectal disorder


subject: UMLS:C3827032

object_name: colorectal neoplasm


subject: UMLS:C3827032

object_name: colonic disease


subject: UMLS:C3827032

object_name: intestinal disorder


subject: UMLS:C3827032

object_name: digestive system disorder


subject: UMLS:C3827032

object_name: digestive system neoplasm


subject: UMLS:C3827032

object_name: Neoplasm of the gastrointestinal tract


subject: UMLS:C3827032

object_name: intestinal cancer


subject: UMLS:C3827032

object_name: intestinal neoplasm


subject: UMLS:C3827032

object_name: cancer


subject: UMLS:C3827032

object_name: neoplasm


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UNII:8K80YB5GMG

subject_name: Rilonacept

object_name: cardiovascular disorder


subject: UNII:8K80YB5GMG

object_name: chronic kidney disease


subject: UNII:8K80YB5GMG

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C2343505

subject_name: Arcalyst


subject: UMLS:C2343505


subject: UMLS:C2343505


subject: CHEBI:27732

subject_name: Caffeine

object_name: narcolepsy


subject: CHEBI:30742

subject_name: macrogol

object_name: type 2 diabetes mellitus


subject: CHEBI:30742

object_name: Insulin resistance


subject: PR:000012224

subject_name: glycodelin


subject: PR:000012224


subject: CHEBI:10023

subject_name: Voriconazole

object_name: Invasive pulmonary aspergillosis


subject: CHEBI:10023

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:10023

object_name: COPD, severe early onset


subject: CHEBI:10023

object_name: chronic obstructive pulmonary disease


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Thoracic Injury


subject: UNII:B0SV3N7J3H

subject_name: Bicifadine

object_name: Diabetic peripheral neuropathy


subject: UNII:612K359T69

subject_name: ALVESPIMYCIN HYDROCHLORIDE

object_name: intraocular lymphoma


subject: UNII:612K359T69

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:612K359T69

object_name: Mantle cell lymphoma recurrent


subject: UNII:612K359T69

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UNII:612K359T69

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UNII:612K359T69

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UNII:612K359T69

object_name: anaplastic large cell lymphoma


subject: UNII:612K359T69

object_name: B-cell small lymphocytic lymphoma stage III


subject: UNII:612K359T69

object_name: Mantle cell lymphoma stage IV


subject: UNII:612K359T69

object_name: Mantle cell lymphoma stage III


subject: UNII:612K359T69

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:612K359T69

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UNII:612K359T69

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:612K359T69

object_name: Marginal zone lymphoma recurrent


subject: UNII:612K359T69

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:612K359T69

object_name: Recurrent Adult Burkitt Lymphoma


subject: UNII:612K359T69

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UNII:612K359T69

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: UNII:612K359T69

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UNII:612K359T69

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: UNII:612K359T69

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: UNII:612K359T69

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: UNII:612K359T69

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UNII:612K359T69

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UNII:612K359T69

object_name: angioimmunoblastic T-cell lymphoma


subject: UNII:612K359T69

object_name: splenic marginal zone lymphoma


subject: UNII:612K359T69

object_name: Marginal zone lymphoma stage IV


subject: UNII:612K359T69

object_name: Stage IV Adult Burkitt Lymphoma


subject: UNII:612K359T69

object_name: Stage IV Adult Hodgkin Lymphoma


subject: UNII:612K359T69

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: UNII:612K359T69

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UNII:612K359T69

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: UNII:612K359T69

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: UNII:612K359T69

object_name: nodal marginal zone B-cell lymphoma


subject: UNII:612K359T69

object_name: Marginal zone lymphoma stage III


subject: UNII:612K359T69

object_name: Stage III Adult Burkitt Lymphoma


subject: UNII:612K359T69

object_name: Stage III Adult Hodgkin Lymphoma


subject: UNII:612K359T69

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:612K359T69

object_name: MALT lymphoma


subject: UNII:612K359T69

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:612K359T69

object_name: recurrent cutaneous T-cell lymphoma


subject: UNII:612K359T69

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:612K359T69

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:612K359T69

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UNII:612K359T69

object_name: Cutaneous T-cell lymphoma stage IV


subject: UNII:612K359T69

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:612K359T69

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:612K359T69

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: UNII:612K359T69

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: UNII:612K359T69

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UNII:612K359T69

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: UNII:612K359T69

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C2698077

subject_name: Alvespimycin Hydrochloride

object_name: intraocular lymphoma


subject: UMLS:C2698077

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C2698077

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C2698077

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UMLS:C2698077

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UMLS:C2698077

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C2698077

object_name: anaplastic large cell lymphoma


subject: UMLS:C2698077

object_name: B-cell small lymphocytic lymphoma stage III


subject: UMLS:C2698077

object_name: Mantle cell lymphoma stage IV


subject: UMLS:C2698077

object_name: Mantle cell lymphoma stage III


subject: UMLS:C2698077

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C2698077

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UMLS:C2698077

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C2698077

object_name: Marginal zone lymphoma recurrent


subject: UMLS:C2698077

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C2698077

object_name: Recurrent Adult Burkitt Lymphoma


subject: UMLS:C2698077

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UMLS:C2698077

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: UMLS:C2698077

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UMLS:C2698077

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: UMLS:C2698077

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: UMLS:C2698077

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: UMLS:C2698077

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UMLS:C2698077

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C2698077

object_name: angioimmunoblastic T-cell lymphoma


subject: UMLS:C2698077

object_name: splenic marginal zone lymphoma


subject: UMLS:C2698077

object_name: Marginal zone lymphoma stage IV


subject: UMLS:C2698077

object_name: Stage IV Adult Burkitt Lymphoma


subject: UMLS:C2698077

object_name: Stage IV Adult Hodgkin Lymphoma


subject: UMLS:C2698077

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: UMLS:C2698077

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C2698077

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C2698077

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: UMLS:C2698077

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C2698077

object_name: Marginal zone lymphoma stage III


subject: UMLS:C2698077

object_name: Stage III Adult Burkitt Lymphoma


subject: UMLS:C2698077

object_name: Stage III Adult Hodgkin Lymphoma


subject: UMLS:C2698077

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C2698077

object_name: MALT lymphoma


subject: UMLS:C2698077

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C2698077

object_name: recurrent cutaneous T-cell lymphoma


subject: UMLS:C2698077

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C2698077

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C2698077

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UMLS:C2698077

object_name: Cutaneous T-cell lymphoma stage IV


subject: UMLS:C2698077

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C2698077

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C2698077

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: UMLS:C2698077

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: UMLS:C2698077

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UMLS:C2698077

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: UMLS:C2698077

object_name: Waldenstrom macroglobulinemia


subject: PUBCHEM.COMPOUND:167713195

subject_name: leritrelvir

object_name: Drug Interactions


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:77733

subject_name: Verapamil


subject: PUBCHEM.COMPOUND:4240

subject_name: Mometasone furoate

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:4240

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:4240

object_name: breast cancer


subject: PUBCHEM.COMPOUND:4240

object_name: Radiation Sickness


subject: PUBCHEM.COMPOUND:4240

object_name: Skin Reaction Secondary to Radiation Therapy


subject: PUBCHEM.COMPOUND:4240

object_name: Dermatologic Complication


subject: CHEBI:6970

subject_name: Mometasone


subject: CHEBI:6970


subject: CHEBI:6970


subject: CHEBI:6970


subject: CHEBI:6970


subject: CHEBI:6970


subject: UMLS:C0962969

subject_name: RAD 001

object_name: Neoplasm Metastasis


subject: UNII:6XN50U405Y

subject_name: tezampanel

object_name: opiate dependence


subject: PUBCHEM.COMPOUND:9925665

subject_name: Tezampanel


subject: CHEBI:64198

subject_name: Dimercaprol

object_name: asthma


subject: CHEBI:64198

object_name: Allergy


subject: CHEBI:231087

subject_name: Trilaciclib

object_name: myelosuppression


subject: UMLS:C2348261

subject_name: Dietary Chromium

object_name: type 2 diabetes mellitus


subject: UMLS:C2348261

object_name: Diabetes


subject: UMLS:C2348261

object_name: diabetes mellitus


subject: CHEBI:28073

subject_name: Chromium


subject: CHEBI:28073


subject: CHEBI:28073


subject: CHEBI:49544

subject_name: Chromic cation


subject: CHEBI:49544


subject: CHEBI:49544


subject: UMLS:C5853669

object_name: xerophthalmia


subject: UMLS:C5853669

object_name: dry eye syndrome


subject: UMLS:C5853669

object_name: Dry Eye Syndrome, CTCAE


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: osteoporosis


subject: CHEBI:35475

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:35475

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:35475

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:35475

object_name: sarcopenia


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0003211


subject: UMLS:C0003211


subject: UMLS:C0003211


subject: UMLS:C0003211


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: UMLS:C3536840


subject: UMLS:C3536840


subject: UMLS:C3536840


subject: UMLS:C3536840


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: UMLS:C4763757

subject_name: Erfonrilimab

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5854644

subject_name: Anti-PD-L1/PD-L2 Bispecific Antibody IMGS-001

object_name: Childhood Solid Neoplasm


subject: UMLS:C5854644

object_name: Adult Solid Neoplasm


subject: UMLS:C5854644

object_name: Solid Neoplasm


subject: CHEBI:59204

subject_name: Carbetocin

object_name: myoma


subject: CHEBI:135905

subject_name: Terlipressin


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297828


subject: UMLS:C4725109


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: UNII:KWH46ZDG32

object_name: adult lymphoma


subject: UNII:KWH46ZDG32

object_name: lymphoma


subject: UNII:KWH46ZDG32

object_name: pediatric lymphoma


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: adult dermatomyositis


subject: UNII:N5UK68MGDZ

object_name: dermatomyositis


subject: CHEBI:4875

subject_name: Etanercept

object_name: Inguinal hernia


subject: CHEBI:4875

object_name: Post-Operative Pain


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: UMLS:C1446777

subject_name: Rabbit antigen

object_name: Fanconi anemia


subject: UMLS:C1446777

object_name: Fanconi anemia complementation group A


subject: UMLS:C1446777

object_name: acute myeloid leukemia


subject: UMLS:C1446777

object_name: Myelodysplasia


subject: UMLS:C2093603

subject_name: Rabbit


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: UMLS:C4722505

subject_name: Goodbelly Probiotic

object_name: coronary artery disorder


subject: UMLS:C4722505

object_name: coronary atherosclerosis


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: UMLS:C4548896

object_name: secondary progressive multiple sclerosis


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Encounter for Menstrual regulation


subject: CHEBI:63610

object_name: Irregular menstruation


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Chronic inflammation


subject: CHEBI:5959

subject_name: Irbesartan

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:5959

object_name: metabolic syndrome X


subject: CHEBI:6121

subject_name: Ketamine

object_name: anxiety


subject: CHEBI:6121

object_name: anxiety disorder


subject: CHEBI:6121

object_name: Anxiety symptoms


subject: CHEBI:6121

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:6121

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:6121

object_name: Hyperalgesia, Thermal


subject: UNII:QQA9MLH692

subject_name: Tafasitamab

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C2987409


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrence


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent Malignant Neoplasm


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent disease


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent tumor


subject: PUBCHEM.COMPOUND:11654566

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:11654566

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:11654566

object_name: Metastasis


subject: PUBCHEM.COMPOUND:11654566

object_name: Metastatic Lesion


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:135632

subject_name: Camostat


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:91397

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:231679

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:231679

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:231679

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:231679

object_name: Richter syndrome


subject: CHEBI:4670

subject_name: Dobutamine

object_name: asthma


subject: CHEBI:4670

object_name: chronic obstructive pulmonary disease


subject: CHEBI:4670

object_name: coronary artery disorder


subject: CHEBI:4670

object_name: coronary atherosclerosis


subject: CHEBI:4670

object_name: cardiovascular surgery result: angina


subject: CHEBI:4670

object_name: Angina pectoris


subject: UNII:2XLN4Y044H

subject_name: REGADENOSON


subject: UNII:2XLN4Y044H


subject: UNII:2XLN4Y044H


subject: UNII:2XLN4Y044H


subject: PUBCHEM.COMPOUND:22451303

subject_name: Regadenoson


subject: PUBCHEM.COMPOUND:22451303


subject: PUBCHEM.COMPOUND:22451303


subject: PUBCHEM.COMPOUND:22451303


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: hypercholesterolemia, familial, 1


subject: UNII:LKC0U3A8NJ

object_name: familial hypercholesterolemia


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: ameloblastoma


subject: CHEBI:75998

subject_name: Trametinib


subject: PUBCHEM.COMPOUND:121481566

object_name: Advanced cancer


subject: UMLS:C4764321


subject: UNII:VJ3OXN6K2H


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: ptosis


subject: UMLS:C1510693

object_name: Plasmodium falciparum malaria


subject: CHEBI:6121

object_name: traumatic encephalopathy


subject: CHEBI:6121

object_name: traumatic brain injury


subject: CHEBI:6121

object_name: intracranial hypertension


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: diabetic retinopathy


subject: UNII:Z7R1B16M02

object_name: Hay fever


subject: CHEBI:75551


subject: CHEBI:63634

subject_name: Valdecoxib

object_name: pharyngitis


subject: CHEBI:63634

object_name: Pharyngitis, CTCAE


subject: CHEBI:78320

subject_name: Lactic acid

object_name: vulvovaginal candidiasis


subject: CHEBI:78320

object_name: bacterial vaginosis


subject: CHEBI:5558

subject_name: Guanfacine

object_name: borderline personality disorder


subject: UMLS:C0242580

subject_name: Tenex


subject: CHEBI:3219

subject_name: Bupropion

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:3219

object_name: obesity


subject: CHEBI:3219

object_name: Obesity, CTCAE


subject: CHEBI:3219

object_name: Overweight


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:27732


subject: CHEBI:27732


subject: CHEBI:27732


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: PUBCHEM.COMPOUND:168429725

subject_name: survodutide


subject: UNII:2ALA66NS64

subject_name: SURVODUTIDE


subject: CHEBI:681569

subject_name: Clofarabine

object_name: Acute myeloid leukemia in remission


subject: CHEBI:23359

subject_name: colchicine

object_name: Intercritical gout


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: head and neck squamous cell carcinoma


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:194425

subject_name: Lobaplatin


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEBI:192744

subject_name: lobaplatin


subject: CHEBI:31898

subject_name: Nedaplatin


subject: CHEMBL.COMPOUND:CHEMBL3137685

subject_name: NEDAPLATIN


subject: CHEBI:40799

subject_name: Boldione

object_name: Castration-Sensitive Prostate Carcinoma


subject: UMLS:C5962170

subject_name: Androgen Receptor Pathway Inhibitor


subject: UNII:P76B05O5V6

subject_name: Relugolix


subject: CHEBI:192805

subject_name: Varespladib methyl

object_name: Snake Bites


subject: CHEBI:192805

object_name: Snakebite Envenoming


subject: CHEBI:90930

subject_name: Aripiprazole lauroxil

object_name: schizophrenia


subject: CHEBI:84500

subject_name: varenicline

object_name: asthma


subject: UMLS:C5943429

subject_name: Serine proteinase-1

object_name: angina unstable


subject: UMLS:C5943429

object_name: coronary artery disorder


subject: UMLS:C5943429

object_name: coronary atherosclerosis


subject: UMLS:C5943429

object_name: coronary restenosis


subject: UMLS:C5943253


subject: UMLS:C5943253


subject: UMLS:C5943253


subject: UMLS:C5943253


subject: UNII:C825F38B80

object_name: non-small cell lung carcinoma


subject: UNII:C825F38B80

object_name: Childhood Solid Neoplasm


subject: UNII:C825F38B80

object_name: Adult Solid Neoplasm


subject: UNII:C825F38B80

object_name: Solid Neoplasm


subject: UMLS:C5447751

subject_name: SHP2 Inhibitor BBP-398


subject: UMLS:C5447751


subject: UMLS:C5447751


subject: UMLS:C5447751


subject: UNII:I92BM16NTD

subject_name: BAPOTULIMAB

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:I92BM16NTD


subject: UMLS:C4744860

subject_name: Bapotulimab


subject: UMLS:C4744860


subject: UMLS:C0021027

subject_name: Immunoglobulins

object_name: hepatitis B


subject: UMLS:C0021027

object_name: viral hepatitis


subject: UMLS:C0021027

object_name: liver disorder


subject: UNII:55G92WGH3X

subject_name: Telacebec


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: bacterial infectious disease


subject: CHEBI:6909

subject_name: Metronidazole


subject: UMLS:C4725090

subject_name: ALK/c-Met Inhibitor TQ-B3139

object_name: Advanced cancer


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: primary central nervous system lymphoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: Primary hypercholesterolemia


subject: CHEMBL.COMPOUND:CHEMBL4594571

object_name: multiple system atrophy


subject: PUBCHEM.COMPOUND:127236

object_name: plasma cell myeloma


subject: PR:000001406

subject_name: tumor necrosis factor receptor superfamily member 17


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Geographic atrophy


subject: CHEBI:85078

object_name: retinal degeneration


subject: CHEBI:85078

object_name: retinal disease


subject: CHEBI:85078

object_name: Pathological Conditions, Anatomical


subject: CHEBI:85078

object_name: eye disorder


subject: CHEBI:132774

subject_name: Roxadustat

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C3713379


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: Adult Mixed Cellularity Classical Hodgkin Lymphoma


subject: CHEBI:64153

object_name: Hodgkin's lymphoma, lymphocytic depletion


subject: CHEBI:64153

object_name: Adult Nodular Sclerosis Classical Hodgkin Lymphoma


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:41500

subject_name: Phenylbutyrates

object_name: Huntington disease


subject: UMLS:C4287666

subject_name: Fluorine F 18 Clofarabine

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4287666

object_name: Embolism, Tumor


subject: UMLS:C4287666

object_name: Neoplasm Metastasis


subject: UMLS:C4287666

object_name: esophageal adenocarcinoma


subject: UMLS:C4287666

object_name: lung adenocarcinoma


subject: UMLS:C4287666

object_name: cervical adenocarcinoma


subject: UMLS:C4287666

object_name: adenocarcinoma


subject: UMLS:C4287666

object_name: bile duct adenocarcinoma


subject: UMLS:C4287666

object_name: gastric adenocarcinoma


subject: UMLS:C4287666

object_name: carcinoma


subject: CHEBI:77590

subject_name: Armodafinil

object_name: binge eating


subject: CHEBI:77590

object_name: Overweight


subject: CHEBI:77590

object_name: obesity


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:39585

subject_name: Carbidopa

object_name: Fractured tibia


subject: CHEBI:39585

object_name: Fractured ankle


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: PUBCHEM.COMPOUND:521372


subject: CHEBI:231679

subject_name: ipilimumab

object_name: nerve sheath neoplasm


subject: CHEBI:231679

object_name: peripheral nervous system neoplasm


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C3658638

object_name: Estrogen Receptor Positive


subject: UMLS:C3658638

object_name: breast carcinoma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: female reproductive system neoplasm


subject: UMLS:C3827082


subject: CHEBI:134689

subject_name: Rucaparib


subject: CHEBI:7421

subject_name: NAC

object_name: chronic kidney disease


subject: UMLS:C4053601

object_name: Stage IIIC Prostate Cancer AJCC v8


subject: UMLS:C4053601

object_name: Stage IV Prostate Cancer AJCC v6


subject: UMLS:C4053601

object_name: Carcinoma of the prostate stage IV


subject: UMLS:C4053601

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C4053601

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C4053601

object_name: Stage III Prostate Cancer AJCC v8


subject: UMLS:C4053601

object_name: Stage III Prostate Cancer AJCC v7


subject: UMLS:C4053601

object_name: Carcinoma of the prostate stage III


subject: UMLS:C4053601

object_name: Stage III Prostate Cancer AJCC v6


subject: UMLS:C4053601

object_name: Stage IVA Prostate Cancer AJCC v8


subject: UMLS:C4053601

object_name: Stage IVB Prostate Cancer AJCC v8


subject: UMLS:C4053601

object_name: Stage IIIB Prostate Cancer AJCC v8


subject: UMLS:C4053601

object_name: Stage IIIA Prostate Cancer AJCC v8


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:157802

subject_name: Cys-Arg

object_name: Restless legs


subject: CHEBI:28073

subject_name: Chromium


subject: CHEBI:49544

subject_name: Chromic cation


subject: PR:000004968

subject_name: calretinin


subject: PR:000006466

subject_name: dehydrogenase/reductase SDR family member 4


subject: PR:000025662

subject_name: complement decay-accelerating factor


subject: UniProtKB:Q8VHX2

subject_name: EDAD_MOUSE Ectodysplasin-A receptor-associated adapter protein (sprot)


subject: PR:000006889

subject_name: ectodysplasin-A receptor-associated adapter protein


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Injury of kidney


subject: UMLS:C5416840

subject_name: Platelet Lysate

object_name: Persistent corneal epithelial defect


subject: UMLS:C5557596

subject_name: Myc Inhibitor OMO-103

object_name: pediatric osteosarcoma


subject: UMLS:C5557596

object_name: Osteosarcoma


subject: CHEBI:57986

object_name: psoriasis


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: Bipolar II disorder, most recent episode major depressive


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: liver disorder


subject: MESH:D000086663

object_name: Vaccine adverse reaction


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: UMLS:C5400806


subject: CHEBI:30879

subject_name: alcohol

object_name: type 2 diabetes mellitus


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: MESH:D004043

subject_name: Dietary Fiber

object_name: diarrhea


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: bipolar disorder


subject: UMLS:C3714131

subject_name: ITCA 650


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:57692

object_name: T-Cell Lymphoma


subject: CHEBI:73627

subject_name: Phe-Ala-Asp


subject: PUBCHEM.COMPOUND:703

subject_name: Flavinat


subject: CHEBI:16238

subject_name: FAD


subject: UMLS:C3896920

subject_name: MDM2/MDMX Inhibitor ALRN-6924

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3896920

object_name: acute myeloid leukemia


subject: UMLS:C3896920

object_name: Myelodysplasia


subject: UMLS:C5238421

subject_name: PARP Inhibitor NMS-03305293

object_name: small cell lung carcinoma


subject: CHEBI:9150

subject_name: Simvastatin

object_name: acute lymphoblastic leukemia


subject: CHEBI:9150

object_name: Muscle strain


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: leukopenia


subject: PUBCHEM.COMPOUND:14907381

object_name: neutropenia


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381

object_name: rectal discharge diarrhea (physical finding)


subject: PUBCHEM.COMPOUND:14907381

object_name: Diarrhea, CTCAE


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:41423

subject_name: Celecoxib

object_name: colorectal cancer


subject: CHEBI:41423

object_name: colorectal carcinoma


subject: CHEBI:41423

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22


subject: PR:000014196


subject: PR:000014196


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: PR:000001919


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: myocardial ischemia


subject: PUBCHEM.COMPOUND:155543961

object_name: Angina pectoris


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C0007220

subject_name: Cardiovascular Agents

object_name: myocardial infarction


subject: UMLS:C0007220

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C0007220

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:180653

subject_name: Molnupiravir

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: oligohydramnios


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Neuromuscular inhibition


subject: CHEBI:60789

object_name: Surgical procedure finding


subject: CHEBI:60789

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:60789

object_name: obesity


subject: CHEBI:60789

object_name: Obesity, CTCAE


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: UMLS:C4278755

object_name: Conn's syndrome


subject: CHEBI:6121

subject_name: Ketamine

object_name: mental disorder


subject: CHEBI:6121

object_name: psychiatric disorder


subject: CHEBI:3641

subject_name: Chlorotrianisene

object_name: Unresectable Hepatocellular Carcinoma


subject: UMLS:C0723595

subject_name: Tace


subject: UMLS:C3493499

object_name: Cognitive impairment


subject: CHEBI:73611

subject_name: Met-Gly

object_name: No-Reflow Phenomenon


subject: CHEBI:73611

object_name: ST-elevation myocardial infarction


subject: CHEBI:73611

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin


subject: PUBCHEM.COMPOUND:73151030


subject: PUBCHEM.COMPOUND:73151030


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: Incarceration


subject: CHEBI:82699

subject_name: Oritavancin

object_name: Substance Use Disorders


subject: CHEBI:82699

object_name: Soft Tissue Infection


subject: CHEBI:82699

object_name: Acute osteomyelitis


subject: CHEBI:82699

object_name: bacterial arthritis


subject: CHEBI:82699

object_name: Infected joint


subject: CHEBI:82699

object_name: bacteriemia


subject: CHEBI:82699

object_name: Bacteremia, CTCAE


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: HIV-1 infection


subject: UMLS:C4733690

subject_name: BTK Inhibitor ICP-022

object_name: Secondary Central Nervous System Lymphoma


subject: UMLS:C4733690

object_name: primary central nervous system lymphoma


subject: UMLS:C2933615

subject_name: LCZ 696

object_name: essential hypertension


subject: UMLS:C3272757

subject_name: Live attenuated Influenza virus antigen only vaccine product

object_name: Influenza B virus infection


subject: UMLS:C3272757

object_name: Influenza A virus infection


subject: PR:000009872

subject_name: endoplasmic reticulum junction formation protein lunapark

object_name: viral disease


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: Diabetes


subject: CHEBI:10119

object_name: diabetes mellitus


subject: CHEBI:229764

subject_name: Selinexor

object_name: Diabetic foot ulcer


subject: UMLS:C2958914

subject_name: INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT

object_name: multiple sclerosis


subject: CHEMBL.COMPOUND:CHEMBL4594340

subject_name: POSOLEUCEL

object_name: adenoviridae infectious disease


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: Metastatic non-small cell lung cancer


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:56588OP40D

subject_name: interferon alfacon-1

object_name: hepatitis C


subject: UNII:56588OP40D

object_name: chronic hepatitis C virus infection


subject: UMLS:C0164613

subject_name: Infergen


subject: UMLS:C0164613


subject: UMLS:C4724944

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C4724944

object_name: Malignant Solid Neoplasm


subject: KEGG.COMPOUND:C00816

subject_name: Collagenase

object_name: decubitus ulcer


subject: UNII:9X7O8V25IT

subject_name: collagenase


subject: UNII:JCL936W835

object_name: Solid Neoplasm


subject: CHEBI:51098

subject_name: Motesanib

object_name: rectal carcinoma


subject: CHEBI:51098

object_name: rectal cancer


subject: CHEBI:51098

object_name: Childhood Rectal Carcinoma


subject: CHEBI:51098

object_name: colon carcinoma


subject: CHEBI:51098

object_name: colorectal cancer


subject: CHEBI:51098

object_name: colon cancer


subject: UMLS:C1541476

subject_name: AMG 706


subject: UMLS:C1541476


subject: UMLS:C1541476


subject: UMLS:C1541476


subject: UMLS:C1541476


subject: UMLS:C1541476


subject: CHEBI:61080

subject_name: Romidepsin

object_name: adult lymphoma


subject: CHEBI:61080

object_name: lymphoma


subject: CHEBI:61080

object_name: pediatric lymphoma


subject: CHEBI:61080

object_name: cancer


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: PUBCHEM.COMPOUND:2269

object_name: Reiter Syndrome


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:3962

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:3962

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:3962

object_name: breast cancer


subject: PUBCHEM.COMPOUND:3962

object_name: Radiation Sickness


subject: CHEBI:40303

subject_name: Lovastatin


subject: CHEBI:40303


subject: CHEBI:40303


subject: CHEBI:40303


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: hepatitis C


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396

object_name: liver cirrhosis


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:35341

subject_name: steroid


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: UMLS:C5782153


subject: CHEBI:8499

subject_name: Propranolol

object_name: traumatic encephalopathy


subject: CHEBI:8499

object_name: traumatic brain injury


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:42797


subject: CHEBI:233309

subject_name: Adagrasib

object_name: digestive system cancer


subject: CHEBI:233309

object_name: lung cancer


subject: CHEBI:233309

object_name: lung neoplasm


subject: CHEBI:233309

object_name: lung carcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: UMLS:C3473073

subject_name: Elelyso

object_name: Gaucher disease type I


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: osteoarthritis of both knees


subject: CHEBI:150712

object_name: Cartilage injury


subject: CHEBI:150712

object_name: meniscus; disorder


subject: CHEBI:135738

subject_name: Clevidipine

object_name: subarachnoid hemorrhage


subject: CHEBI:135738

object_name: Intracranial Hemorrhage, CTCAE


subject: CHEBI:135738

object_name: Intracranial hemorrhage


subject: UMLS:C5446484

subject_name: Copper Cu 64-DOTA-pembrolizumab

object_name: Metastatic Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:162677505

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:162677505

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:162677505

object_name: breast cancer


subject: PUBCHEM.COMPOUND:162677505

object_name: melanoma


subject: UNII:D23R36L5QY

subject_name: Pudexacianinium Chloride


subject: UNII:D23R36L5QY


subject: UNII:D23R36L5QY


subject: UNII:D23R36L5QY


subject: UMLS:C5420902


subject: UMLS:C5420902


subject: UMLS:C5420902


subject: UMLS:C5420902


subject: UMLS:C1136571

object_name: endogenous depression


subject: UMLS:C1136571

object_name: major depressive disorder


subject: CHEBI:40279

subject_name: Allopurinol

object_name: hypertension


subject: CHEBI:40279

object_name: Hypertension, CTCAE


subject: CHEBI:40279

object_name: Left ventricular hypertrophy


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: metastatic prostate carcinoma


subject: UMLS:C3827082


subject: CHEBI:8382

subject_name: Prednisone


subject: UMLS:C5435429

object_name: primary biliary cholangitis


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Osteosarcoma


subject: PUBCHEM.COMPOUND:2767

object_name: bone sarcoma


subject: CHEBI:4305

subject_name: dacarbazine


subject: CHEBI:4305


subject: CHEBI:4305

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:4305

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:4305

object_name: sarcoma


subject: CHEBI:4305

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:4305

object_name: soft tissue sarcoma


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEBI:38940


subject: UMLS:C0658617

object_name: endometrial cancer


subject: UMLS:C0658617

object_name: uterine corpus cancer


subject: UMLS:C0658617

object_name: endometrial carcinoma


subject: UMLS:C0658617

object_name: ovarian cancer


subject: UMLS:C0658617

object_name: ovarian neoplasm


subject: UMLS:C0658617

object_name: ovarian carcinoma


subject: CHEBI:177298

object_name: BRCA1 gene mutation


subject: CHEBI:177298

object_name: BRCA2 gene mutation


subject: CHEBI:177298

object_name: breast carcinoma


subject: CHEBI:177298

object_name: Her2-receptor negative breast cancer


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:59594

subject_name: Colesevelam

object_name: Diarrhea predominant irritable bowel syndrome


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: Surgical Wound Infection


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Colon Neoplasm


subject: PUBCHEM.COMPOUND:137706467

subject_name: Rimiducid

object_name: uveal melanoma


subject: PUBCHEM.COMPOUND:137706467

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:137706467

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:137706467

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:137706467

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:137706467

object_name: acute myeloid leukemia


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Congenital heart disease in children


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: duodenal ulcer


subject: CHEBI:50275

object_name: Duodenal Ulcer, CTCAE


subject: CHEBI:5390

subject_name: Glu-Glu

object_name: Uses contraception (finding)


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Distal Radius Fractures


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: interstitial lung disease


subject: CHEBI:5801

object_name: hereditary pulmonary alveolar proteinosis


subject: UNII:25E79B5CTM

subject_name: Denileukin diftitox

object_name: pancreatic neoplasm


subject: UNII:25E79B5CTM

object_name: exocrine pancreatic carcinoma


subject: UNII:25E79B5CTM

object_name: malignant pancreatic neoplasm


subject: UNII:25E79B5CTM

object_name: lung cancer


subject: UNII:25E79B5CTM

object_name: lung neoplasm


subject: UNII:25E79B5CTM

object_name: lung carcinoma


subject: UNII:25E79B5CTM

object_name: colorectal cancer


subject: UNII:25E79B5CTM

object_name: colorectal carcinoma


subject: UNII:25E79B5CTM

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:25E79B5CTM

object_name: Childhood Breast Carcinoma


subject: UNII:25E79B5CTM

object_name: breast carcinoma


subject: UNII:25E79B5CTM

object_name: breast cancer


subject: UNII:25E79B5CTM

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: CHEBI:9123

subject_name: Sertraline

object_name: Persistent postural perceptual dizziness


subject: CHEBI:9123

object_name: Migrainous vertigo


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:77733


subject: MESH:C000721868

subject_name: TURKOVAC


subject: UMLS:C5205493

subject_name: Pucotenlimab

object_name: bladder tumor


subject: UMLS:C5205493

object_name: urinary bladder carcinoma


subject: UMLS:C5205493

object_name: urinary bladder cancer


subject: UMLS:C5205493

object_name: childhood bladder carcinoma


subject: UMLS:C2347906

subject_name: Anpocogin

object_name: coronary artery disorder


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Atrophic acne scar


subject: UNII:6I3O3W6O3B

subject_name: Entospletinib

object_name: chronic graft versus host disease


subject: CHEBI:27470

subject_name: Folic acid

object_name: Menopause present (finding)


subject: CHEBI:27470

object_name: Menopause


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Escherichia coli food poisoning


subject: UNII:D26C95A960

object_name: Alzheimer disease


subject: UMLS:C4310555

object_name: bacterial infectious disease


subject: CHEBI:134722

subject_name: Favipiravir


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:133021

subject_name: Venetoclax


subject: PUBCHEM.COMPOUND:71526745

object_name: Overweight and obesity


subject: PUBCHEM.COMPOUND:71526745

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:71526745

object_name: obesity


subject: PUBCHEM.COMPOUND:71526745

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:71526745

object_name: Weight loss


subject: PUBCHEM.COMPOUND:71526745

object_name: Weight Loss, CTCAE


subject: MESH:C000720429


subject: MESH:C000720429


subject: MESH:C000720429


subject: MESH:C000720429


subject: MESH:C000720429


subject: MESH:C000720429


subject: UMLS:C2353772

object_name: Postoperative ileus


subject: CHEBI:5441

subject_name: Glyburide

object_name: Pregnant


subject: UMLS:C3714501

subject_name: Insulin Drug Class


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:7986

object_name: acute pancreatitis


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: spinal muscular atrophy


subject: CHEBI:44423

object_name: proximal spinal muscular atrophy


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Human Immunodeficiency Virus Positive


subject: UMLS:C3273463

subject_name: Oncoxin

object_name: liver carcinoma


subject: CHEBI:95021

subject_name: pemetrexed

object_name: glioma


subject: CHEBI:95021

object_name: malignant glioma


subject: CHEBI:63724


subject: CHEBI:63724


subject: UMLS:C0042210

subject_name: Vaccines

object_name: SARS-CoV-2 acute respiratory disease


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: nephrotic syndrome


subject: UNII:4Z63YK6E0E

object_name: Nephrotic Syndrome, CTCAE


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:8382

subject_name: Prednisone

object_name: HIV-associated nephropathy


subject: CHEBI:8382

object_name: HIV infection


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Metastatic malignant neoplasm to liver


subject: UNII:28X28X9OKV

object_name: colorectal cancer


subject: UNII:28X28X9OKV

object_name: colorectal carcinoma


subject: UNII:28X28X9OKV

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: non-small cell lung carcinoma


subject: UNII:4Z63YK6E0E

object_name: Personal wellbeing status


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Control of hip fracture risk


subject: CHEBI:9130

object_name: hip fracture


subject: CHEBI:4445

subject_name: Desflurane


subject: CHEBI:4445


subject: UMLS:C0061183

subject_name: Gelofusin

object_name: decubitus ulcer


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:5458171

object_name: acute myeloid leukemia


subject: CHEBI:229764

subject_name: Selinexor


subject: CHEBI:229764


subject: PUBCHEM.COMPOUND:4056

subject_name: vitamin K2

object_name: Osteopenia


subject: PUBCHEM.COMPOUND:4056

object_name: osteoporosis


subject: PUBCHEM.COMPOUND:4056

object_name: Encounter due to family history of osteoporosis


subject: PUBCHEM.COMPOUND:4056

object_name: Osteoporosis, CTCAE 5.0


subject: PUBCHEM.COMPOUND:4056

object_name: Osteoporosis, CTCAE 3.0


subject: UNII:71ANL51TLA

subject_name: Menaquinone 6


subject: UNII:71ANL51TLA


subject: UNII:71ANL51TLA


subject: UNII:71ANL51TLA


subject: UNII:71ANL51TLA


subject: PUBCHEM.COMPOUND:14236712

subject_name: Withanolide B


subject: PUBCHEM.COMPOUND:14236712


subject: PUBCHEM.COMPOUND:14236712


subject: PUBCHEM.COMPOUND:14236712


subject: PUBCHEM.COMPOUND:14236712


subject: PUBCHEM.COMPOUND:5280374


subject: PUBCHEM.COMPOUND:5280374


subject: PUBCHEM.COMPOUND:5280374


subject: PUBCHEM.COMPOUND:5280374


subject: PUBCHEM.COMPOUND:5280374


subject: CHEBI:28869

subject_name: Menadione


subject: CHEBI:28869


subject: CHEBI:28869


subject: CHEBI:28869


subject: CHEBI:28869


subject: UNII:12V8PA4WCH

subject_name: Menaquinone


subject: UNII:12V8PA4WCH


subject: UNII:12V8PA4WCH


subject: UNII:12V8PA4WCH


subject: UNII:12V8PA4WCH


subject: CHEBI:16374

subject_name: Menatetrenone


subject: CHEBI:16374


subject: CHEBI:16374


subject: CHEBI:16374


subject: CHEBI:16374


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: dendritic cell deficiency


subject: PR:000005931


subject: UNII:PA05MFH3I7

object_name: Refractory acute myeloid leukemia


subject: UNII:PA05MFH3I7

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:PA05MFH3I7

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:16171

subject_name: NMN zwitterion

object_name: Diminished ovarian reserve


subject: CHEBI:14648

subject_name: NMN(+)


subject: CHEBI:18248

subject_name: Iron

object_name: malaria


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: PR:000007515

subject_name: four and a half LIM domains protein 5


subject: PR:000007515

object_name: anemia


subject: PR:000007515

object_name: Iron deficiency


subject: PR:000007515

object_name: iron deficiency anemia


subject: PR:000014683


subject: PR:000014683


subject: PR:000014683


subject: PR:000014683


subject: PR:000023516

subject_name: pyruvate formate-lyase 1-activating enzyme


subject: PR:000023516


subject: PR:000023516


subject: PR:000023516


subject: UniProtKB:P0A9N4

subject_name: PFLA_ECOLI Pyruvate formate-lyase 1-activating enzyme (sprot)


subject: UniProtKB:P0A9N4


subject: UniProtKB:P0A9N4


subject: UniProtKB:P0A9N4


subject: DRUGBANK:DB05404

object_name: Heartburn


subject: DRUGBANK:DB05404

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: MESH:C112734

subject_name: AIDSVAX

object_name: HIV infection


subject: MESH:C089950

subject_name: MF59 oil emulsion


subject: UNII:8GJK87S89F

subject_name: TREPROSTINIL PALMITIL

object_name: pulmonary hypertension


subject: UNII:8GJK87S89F

object_name: Pulmonary Hypertension, CTCAE


subject: DRUGBANK:DB18792

subject_name: Treprostinil palmitil


subject: DRUGBANK:DB18792


subject: UNII:C5529G5JPQ

subject_name: ginger extract

object_name: Atopic rhinitis


subject: UMLS:C5666934

subject_name: Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody MVR-C5252

object_name: Recurrent Malignant Glioma


subject: DRUGBANK:DB18996

subject_name: Povetacicept

object_name: membranous glomerulonephritis


subject: DRUGBANK:DB18996

object_name: lupus nephritis


subject: DRUGBANK:DB18996

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: DRUGBANK:DB18996

object_name: IgA Nephropathy


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:27991

object_name: blood coagulation disease


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: PUBCHEM.COMPOUND:16051933


subject: UNII:6WKC8VL781

object_name: Coma, Post-Head Injury


subject: UMLS:C2350959


subject: CHEBI:70839

subject_name: Dasatinib

object_name: acute lymphoblastic leukemia


subject: CHEBI:190514


subject: CHEBI:49375


subject: UMLS:C5771264

subject_name: Nexobrid

object_name: Thermal burn


subject: CHEBI:230430

subject_name: Ulinastatin

object_name: liver carcinoma


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: UMLS:C0077906


subject: CHEBI:95021

subject_name: pemetrexed

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:63724


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:4702

subject_name: Dorzolamide

object_name: low tension glaucoma


subject: CHEBI:60787

subject_name: TIMOLOL


subject: CHEBI:39465

subject_name: timolol


subject: CHEBI:63925

subject_name: PhXa 85


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: influenza


subject: CHEBI:2704

subject_name: Anastrozole

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Early Stage Breast Carcinoma


subject: CHEBI:2704

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:2704

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:6413

subject_name: Letrozole

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:6413

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: UMLS:C2984025

subject_name: Ferinject

object_name: heart failure


subject: UMLS:C2984025

object_name: Iron deficiency


subject: UMLS:C2984025

object_name: iron deficiency anemia


subject: UNII:6897GXD6OE


subject: CHEBI:85078

subject_name: Dapagliflozin


subject: UMLS:C0700599

subject_name: pyrimethamine / sulfadoxine

object_name: Malaria, antepartum


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: HER2 positive


subject: CHEBI:46261

subject_name: Phenylthiourea


subject: CHEBI:46261

object_name: Childhood Breast Carcinoma


subject: CHEBI:46261

object_name: breast carcinoma


subject: CHEBI:46261

object_name: breast cancer


subject: CHEBI:9168

subject_name: Sirolimus

object_name: anterior uveitis


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:57505028

object_name: Alzheimer disease


subject: CHEBI:8802

subject_name: Remifentanil

object_name: osteoarthritis


subject: CHEBI:83766

subject_name: Olaparib

object_name: cholangiocarcinoma


subject: GTOPDB:5962

subject_name: dovitinib

object_name: Stomach cancer


subject: GTOPDB:5962

object_name: gastric cancer


subject: CHEBI:231683

subject_name: Anakinra

object_name: gout


subject: CHEBI:231683

object_name: chronic kidney disease


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: UMLS:C5239569

subject_name: PhosphoLean

object_name: Impulsivity


subject: PUBCHEM.COMPOUND:129696905

object_name: ST-elevation myocardial infarction


subject: UNII:IKE1P4X57J

subject_name: Aggrastat


subject: CHEBI:9605

subject_name: Tirofiban


subject: GTOPDB:11827

subject_name: telitacicept

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: GTOPDB:11827

object_name: granulomatosis with polyangiitis


subject: CHEMBL.COMPOUND:CHEMBL5095293

subject_name: TELITACICEPT


subject: CHEMBL.COMPOUND:CHEMBL5095293


subject: UMLS:C5238006


subject: UMLS:C5238006


subject: UNII:366037O6O7

subject_name: Irosustat


subject: UNII:366037O6O7


subject: UNII:366037O6O7


subject: UMLS:C3853844


subject: UMLS:C3853844


subject: UMLS:C3853844


subject: CHEBI:15940

subject_name: Niacin

object_name: Excessive body weight gain


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:8871

subject_name: Risperidone

object_name: schizophreniform disorder


subject: DRUGBANK:DB17676

subject_name: Oxabact

object_name: Hyperoxaluria


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Childhood Glioblastoma


subject: CHEBI:31355

object_name: adult glioblastoma


subject: CHEBI:31355

object_name: glioma


subject: CHEBI:31355

object_name: malignant glioma


subject: CHEBI:82977

subject_name: Daclatasvir

object_name: Hepatic impairment


subject: CHEBI:82977

object_name: HIV-1 infection


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: CHEBI:85083


subject: UNII:9X7O8V25IT

subject_name: collagenase

object_name: Dupuytren's Disease


subject: UMLS:C0009053

subject_name: collagenase Clostridium histolyticum


subject: UNII:NJL503AIJA

object_name: multiple sclerosis


subject: CHEBI:8435

subject_name: Prochlorperazine

object_name: plasma cell myeloma


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Anterior Cruciate Ligament Tear


subject: CHEBI:3215

object_name: Knee Injuries


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Angina pectoris


subject: CHEBI:32127

subject_name: sevelamer

object_name: hyperphosphatemia


subject: CHEBI:32127

object_name: Serum phosphate concentrations above normal (finding)


subject: CHEBI:32127

object_name: Hyperphosphatemia, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL5314349

subject_name: SEVELAMER


subject: CHEMBL.COMPOUND:CHEMBL5314349


subject: CHEMBL.COMPOUND:CHEMBL5314349


subject: UNII:9YCX42I8IU

subject_name: sevelamer carbonate


subject: UNII:9YCX42I8IU


subject: UNII:9YCX42I8IU